Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation-Reference-Cited by-同舟云学术

Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation

Published:2020-05-19 Issue:9 Volume:15 Page:1065-1080
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Butler Kevin¹,Le Foll Bernard¹²³⁴⁵

Affiliation:

1. Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada

2. Acute Care Program, Centre for Addiction and Mental Health, Centre for Addiction and Mental Health, Toronto, ON, Canada

3. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada

4. Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada

5. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada

Funder

not funded

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2020.1767581

Reference184 articles.

1. World Health Organization. Tobacco factsheet [updated 2019 May 29; cited 2019 Jun]. Available from: https://www.who.int/news-room/fact-sheets/detail/tobacco

2. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

3. Global economic cost of smoking-attributable diseases

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of anandamide in nicotine addiction;Anandamide in Health and Disease;2025

2. Interfering with reconsolidation by rimonabant results in blockade of heroin-associated memory;Frontiers in Pharmacology;2024-03-21

3. Neurobiology of Stress-Induced Nicotine Relapse;International Journal of Molecular Sciences;2024-01-25

4. Cue-reactivity targeted smoking cessation intervention in individuals with tobacco use disorder: a scoping review;Frontiers in Psychiatry;2023-09-07

5. The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses;Psychological Medicine;2023-09-06